Skip to content
PoliticalRepoPoliticalRepo

United Kingdom · Motion · Early Day Motion

EDM 622

ECULIZUMAB AND aHUS PATIENTS

openUnited Kingdom· UK Parliament· EN

Introduced

11 December 2014

Last action

11 December 2014 · Early Day Motion

Status

0

Sponsors

Keith Vaz

Subjects

Discovery layer

Source updated

11 December 2014

Official sourceShare

Summary

That this House applauds the decision by the National Institute for Health and Care Excellence to recommend that the drug eculizumab be used for treating atypical haemolytic uraemic syndrome (aHUS); notes that this life-threatening disease affects around 200 people in England with 20 to 30 new patients diagnosed with the condition each year; and recognises that a petition of 30,000 signatures was presented to the House calling for the use of this drug.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 11 December 2014

    Early Day Motion

    That this House applauds the decision by the National Institute for Health and Care Excellence to recommend that the drug eculizumab be used for treating atypical haemolytic uraemic syndrome (aHUS); notes that this life-threatening disease affects around 200 people in England with 20 to 30 new patients diagnosed with the condition each year; and recognises that a petition of 30,000 signatures was presented to the House calling for the use of this drug.

    Source: Early Day Motion

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.